Canton Biologics Funding: $41M Raised, Series C (2023)
Canton Biologics is based in Guangzhou, China. It has raised $41M in total funding. Latest round: Series C.
Canton Biologics funding overview
Canton Biologics is based in Guangzhou, China. Canton Biologics has raised $41M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2023. The round record for Canton Biologics runs through 2023; nothing later has been disclosed. Investors on record include SDIC Venture Capital, Guangdong Technology Financial Group, Taipu Life Science Investment, Chnin Financial. 4 distinct backers are named across the disclosed rounds.
Canton Biologics has raised $41M in total disclosed funding across the rounds on record.
Who has invested in Canton Biologics?
SDIC Venture Capital, Guangdong Technology Financial Group, Taipu Life Science Investment, Chnin Financial are named among the investors backing Canton Biologics.
What was the latest Canton Biologics funding round?
The most recent disclosed round is a Series C, announced in September 2023.
Where is Canton Biologics based?
Canton Biologics is based in Guangzhou, China.
When did Canton Biologics last raise?
The last disclosed Canton Biologics round closed in September 2023 at Series C.
We update the Canton Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Guangzhou and their backers are listed below.
